Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Biogen, Eisai’s Alzheimer’s Drug E2609 to Enter Late-Stage Trial
Biogen, Eisai’s Alzheimer’s Drug E2609 to Enter Late-Stage Trial
Biogen, Eisai’s Alzheimer’s Drug E2609 to Enter Late-Stage Trial
Submitted by
admin
on August 9, 2016 - 10:45am
Source:
Bloomberg
News Tags:
Biogen
Eisai
Alzheimer's disease
E2609
Headline:
Biogen, Eisai’s Alzheimer’s Drug E2609 to Enter Late-Stage Trial
Do Not Allow Advertisers to Use My Personal information
